ABSTRACT The major problem with angiogenesis research is the choice of an appropriate assay. Currently, many in vitro and in vivo techniques are available for research into the functions of endothelial cells during angiogenesis. In this historical review article, we describe and evaluate the methodology and specific features of some of the most frequently used of these assays.
Microscopic era
Jean Riolan (1580-1657) injected for the first time color dyes to demonstrate the branching of the vascular tree (Paweletz, 2001) . Marcello Malpighi described capillaries in the renal glomeruli, in the mesentery and in the lung and studied the vasculature of the chick embryo chorioallantoic membrane in his work De ovo incubato published in 1671. He extensively performed vascular injection using ink, urine colored with ink, and black-colored liquid mixed with wine. Frederik Ruysch (1638-1731) used wax to inject the vascular system and proved the presence of the capillary bed in all tissues including vasa vasorum and bronchial capillaries (Hwa and Aird, 2007) .
Diaphanization was also used for studying the vascular system rendering cadaveric tissues transparent by a series of chemical reactions accordingly to a method developed by Spalteholz (Spalteholz and Hirsch, 1907) .
The first description of the endothelium was attributed to Theodor Schwann ( Fig. 2) (Schwann and Schleiden, 1847) . These data were obtained by injection of silver nitrate into the vessels followed by light exposure (Woodward, 1870) , which allowed the definitive establishment of the presence of a cellular lining and hence the existence of a capillary wall. In 1862, von Recklinghausen stained the lymphatics with this method and was the first to observe that they were lined with cells (Warkany, 1981) . In 1865, in his work titled Die Häute und Höhlen des Körpers (The membranes and cavities of the body), the swiss anatomist Wilhelm His used for www.intjdevbiol.com tion that cultured endothelial cells changes in cell shape can signal through integrins to regulate gene expression and DNA synthesis. He went on to develop an entirely new field of investigation of cell biology based on the mechanisms by which mechanical forces modify DNA synthesis and gene expression of emdothelial cells (Ingber et al., 1987) .
Angiogenesis was first observed in vitro by Folkman and Haudenschild (1980) . After long-term culture of capillary endothelial cells, these authors observed the spontaneous organization of these cells into capillary-like structures. Montesano contributed to clarifying some cellular and molecular mechanisms of angiogenesis using an original three-dimensional cell culture system which replicates key events of angiogenesis, thereby facilitating molecular analysis .
In vitro models of angiogenesis have focused on migration, proliferation amd tubule formation by endothelial cells in response to exogenous stimulatory or inhibitory agents. An important consideration when using endothelial cells stabilized in vitro is that they lose their phenotypic, antigenic and functional characteristics. Moreover, as angiogenesis commonly involves the microvasculature rather than the macrovasculature, an inappropriate use of endothelial cell lineages may lead to inaccurate responses.
Ex vivo models to study angiogenesis

Rat aorta explant
This assay was developed by Nicosia and Ottinetti (1990) and subsequently adapted for other species (Fig. 4) . Isolated rat aorta is cut into segments yhat are placed in culture in biological matrices (collagen or fibrin) in the presence of the appropriate stimuli. Over the next 7-14 days, the explants are monitores for the outgrowth of endothelial and other cells. Quantification is achieved by measuring the number and lenght of microvessel outgrowth from the primary explants by visual counting or computer-assisted image analysis. Time-lapse videomicroscopy, immunohistochemical and ultrastructural studies can also be applied. A further modification of Schwann (1810 Schwann ( -1882 . Fig. 3 (Right) . George E. Palade (1912 Palade ( -2008 . Nobel Prize in Physiology and Medicine in 1974. the first time the term endothelium to define the inner layer of the blood vessels (His, 1865; Loukas et al., 2008) .
As concerns the pericytes, in 1873, Rouget described perivascular cells with contractile properties with irregular cell bodies and the branched processes of which encircled the capillaries. In 1886, Zimmerman in 1886 using silver nitrate and in 1902, Mayer using methylene blue were able tostain these cells (Movat and Fernando, 1964) . Moreover, Zimmerman introduced the term "pericyte" to define Rouget cells and postulated that contraction of these cells controls capillary permeability (Allt and Lawrenson, 2001 ). The theory that perciytes are active contractile elements was criticized by Sandison, Clark and Clark, and Zweifach (Sanders et al., 1940; Zweifach and Kossman, 1937) .
Goldman (Goldman, 1907) and Lewis (Lewis, 1936 ) described many differences in the morphology of blood vessels among various tumors in rats and humans. Using a window model elaborated by Sandison (Sandison, 1927) , Ide et al.,(1939) observed a potent angiogenic response after implanting a tumor in a rabbit's ear. Clark used the same experimental model to study the development and function of blood and lymphatic vessels (Clark et al., 1931; Clark, 1936, Clark and Clark, 1939) .
In 1964, Weibel and Palade (Fig. 3 ) described for the first time the so-called "Weibel Palade bodies" in the cytoplasm of endothelial cells (Weibel and Palade, 1964) . Today it is well known that a component of these bodies is von Willebrand factor and the FVIIIrelated antigen antibody is commonly used for the immunostaining of endothelial cells.
In vitro models to study angiogenesis
A critical issue in setting up an in vitro assay is the choice of endothelial cells. Endothelial cells derived form humbilical veins were first successfully cultured in vitro in 1973 by Eric A. Jaffe and co-workers (Jaffe et al., 1973) . The first long-term passage of cloned capillary endothelial cells came later (Haudenschild, et al., 1975) .
Ingber gave an important contribution in this field by demonstra- into slow release pellets, such as Elvax of Hydron. The assay has been adapted for the use in the mouse eye (Muthukkaruppan and Auerbach, 1979) in order to take advantage of imbred strains, transgenic animals and the availability of a number of suitable reagents for these animals.
Chick embryo chorioallantoic membrane assay
The chick embryo chorioallantoic membrane (CAM) was described by experimental embryologists ore than 50 year ago and is probably the most widely used in vivo assay for studying angiogenesis . Folkman and associates introduced this assay in 1974 (Fig. 6) (Auerbach et al., 1974) .
The CAM is a suitable site for transplanting tissues, which can survive and develop in the CAM by peripheral anastomoses between graft and original CAM vasculature or by new angiogenic vessels grown from the CAM that invade the graft. While the formation of peripheral anastomoses between host and pre-existing donor vessels is the main, and the most common, mechanism involved in the revascularization of embryonic grafts, the growth of CAMderived vessels into the graft is only stimulated in tumor grafts.
The CAM has long been a favored system for the study of the rat aortic ring aortic ring assay is the chick aortic arch model.
In vivo models to study angiogenesis
Rabbit ear chamber This is a chronic transparent tissue preparation that was developed by Sandison in 1924 and has been adapted for contnuous non-invasive monitoring of angiogenesis. In 1931, Clark and coworkers perfected the implantation of transpaent chambers in the rabbit's ear, allowing the study of the morphological characteristics of blood vessels in vivo.
Dorsal skin and subcutaneous air sac
The dorsal skin chamber was first introduced by Algire in 1943 and has been adapted for use in other rodents or placed in immunodeficient rodents. This assay permits continuous non invasive monitoring of vascular networks in vivo over 3-4 weeks.
The dorsal air sac model was developed by Selye in 1953 as a mean of monitoring the vascularization of tumor grafts. Cells or tissue fragments were introduced into an air pocket created on the dorsum of a rat temporarily creating a thin isolated vascularized membrane to establish a new blood supply. Angiogenesis was assessed using a dissecting microscope to count vessels or photographs of the skin for quantification of vessel density.
Corneal micropocket assay
The production of an angiogenic reaction in the cornea must be considered the most convincing demonstration of true vascularization, since the cornea is normally completely avascular. In 1973, Folkman and Gimbrone implanted tumor fragments with a size of no more than 0,5mm 3 into the rabbit cornea at a distance of 2 mm from the limbal edge. After 8-10 days new capillary blood vessels grew from the limbus, invaded the cornea and encircled the tumor implant in the absence of inflammation and vascularized tumor grew exponentially (Fig. 5) (Gimbrone, et al., 1973) .
Substances used within the pocket have included tumor tissue, tumor cells, tumor extracts, other tissues and cells, conditioned medium, recombinant cytokines and/or growth factors incorporated tumor angiogenesis and metastasis, because a this stage the chick immunocompetence system is not fully developed and the conditions for rejection have not been established. Tumors remain avascular for 72 h, after which they are penetrated by new blood vessels and begin a phase of rapid growth. The rate of growth during this vascular phase is greater for implants on days 5 and 6, and decreases for later days of implantation. The CAM may also used to verify the ability to inhibit the growth of capillaries by implanting tumors onto the CAM and by comparing tumor growth and vascularization with or without the administration of an antiangiogenic molecule.
Other studies using the tumor cells/CAM model have focused on the invasion of the chorionic epithelium and the blood vessels by tumor cells. The cells invade the epithelium and the mesenchymal connective tissue below, where they are found in the form of a dense bed of blood vessels, which is a target for intravasation.
Also, delivery of tumor cells onto the CAM allows the fine study of the effects of tumor-derived angiogenic growth factors on blood vessel structure and functionality.
The cannulated sponge model
In 1987, Andrade and co-workers described a method of quantitating angiogenesis in sponge implants. After putting the agonist or antagonist of angiogenesis in circular polyether sponge discs with central cannulae, the subsequent change in blood flow can be measured by using the 133 Xe clearance technique for repeated measurement of relative blood flow changes through the sponges over a period of weeks. As the sponges originally contained no blood vessels, the increase in the rate of 133 Xe loss from the sponges was considered to represent neovascularization.
The disc angiogenesis assay
In 1988, Fajardo et al. described a new assay in which polyvinyl alcohol sponges are introduced subcutaneously in the host animal through a distal skin incision and then evaluated for penetration by host-derived blood vessels and/or other cell infiltrates. Angiogenic factors or antagonists are incorporated into a slow release polymer and placed in the centre of the sponge. The disc angiogenesis system has been modified to enable the introduction of live cells, i.e. tumor cells or inflammatory cells into the centre of the sponge.
Discs can be fixed, sectioned and stained. Histological examination of sections of the disc show a rich neovascularization and a distinctive cellular infiltration at the edges, including fibroblasts, endothelial cells and leukocytes.
Morphogenesis on Matrigel
Matrigel, a laminin-rich mixture of basement membrane components, was initially used to investigate capillary tube formation in vitro. Matrigel in liquid form at 4°C is mixed with an angiogenic cytokine and injected in the subcutaneous tissues of mice. At body temperature Matrigel rapidly forms a solid gel, trapping the growth factor to allow slow release and prolonged exposure to surrounding tissues. The animals are killed on day 10 and the Matrigel plugs excised for histologic examination. Angiogenesis is quantitated as vessel area in the plug section by image analysis. The quantitation of the angiogenic response may be also performed by hemoglobin content. This assay was originally described by Passaniti et al. in 1992 , who injected Matrigel-containing FGF-2 subcutaneously into mice.
Zebrafish
The zebrafish (Dario rerio) has been recently introduced as an experimental model to study angiogenesis in vivo (Serbedzija et al., 1999; Chan et al., 2002) . The development of blood vessels, such as the dorsal aorta, posterior cardinal vein, subintestinal veins and intersegmental vessels in early zebrafish embryos is well characterized through analysis of mutations affecting their formation and as the embryos develop outside the mother and are transparent, the direct observation of blood vessel formation is straight forward using just a low-power microscope. Moreover, it is possible to undertake specific gene knockdown by antisense morpholino oligonucleotides, which allow rapid assessment of gene function in angiogenesis.
More recently, Nicoli and Presta (2007) have proposed to use this assay to inject peptides, proteins or tumor cells suspensions in the yolk sac of embryos to evaluate their angiogenic capability (Fig. 7) .
Tumor models
Different in vivo tumor models have been developed to study the activity of anti-cancer treatments. Tumors can be grown syngeneiclly (subcutaneous), orthotopically (in the organ site of origin), or as xenografts in immunodeficient recipient. A major disadvantage of all the tumor models is that tumors are established within a few weeks after cell implantaion, whereas human cancer develops over a period o several months or years. Tumor models can be also used to investigate antiangiogenic drugs.
Concluding remarks
The assays to study angiogenesis in vitro and in vivo have enabled to make up important progress in elucidating the mechanism of action of several angiogenic factors and inhibitors. A variety of animal models have ben described to provide more quantitative analysis of in vivo angiogenesis and to characterize pro-and antiangiogenic molecules.
The ideal assay would be reliable, technically straighforward, easily quantifiable and physiologically relevant. None of the presently used assay systems allows an objective evaluation of the various components of the process of angiogenesis and a 'gold standard'angiogenesis assay has yet to be developed. Ideally, almost two different assays should be performed in parallel to confirm the angiogenic or antiangiogenic activities of test substances.
